logo
  

Big Lots Withdraws Q1, FY20 Outlook Amid COVID-19 Outbreak - Quick Facts

Providing additional business update on the impact of coronavirus (COVID-19) pandemic, discount retailer Big Lots, Inc. (BIG) on Monday withdrew its financial guidance for the first quarter and full year 2020, given the lack of business visibility related to these factors.

The company said it expects to resume the practice of providing an annual outlook when business conditions return to a more normal environment.

Although the company has recently experienced demand volatility, strong sales in March for essential items such as food and consumables has resulted in positive low single digit comps quarter-to-date.

During March, the company also incurred unplanned expenses related to COVID-19, including temporary store and distribution center wage increases, additional store cleaning costs, as well as other items, and expects to incur additional unplanned expenses over the balance of the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
RELATED NEWS
Follow RTT